Skip to content
ClinCalc Pro
Menu
Opioid Analgesic (Weak)

Tramadol

Brand names: Zydol, Tramacet (combination)

Tramadol is a centrally acting opioid analgesic with additional monoaminergic action, used for moderate-to-severe pain; this page covers its use in older people.

Dosing — being independently re-sourced

ClinCalc Pro is rebuilding its dose data from primary open sources — the manufacturer SmPC (eMC), the WHO Model Formulary and other official references — under clinician review. This drug's structured dose is not yet published here. Confirm all doses against the product SmPC and your local formulary before prescribing.

Clinical monograph

How it works

It is a weak mu-opioid receptor agonist that also inhibits reuptake of serotonin and noradrenaline, contributing to analgesia.

Prescribing in practice

  • In older people use cautiously at reduced dose with extended intervals, as they are more susceptible to confusion, sedation, falls, hyponatraemia and constipation, and reduced renal function prolongs exposure.
  • It lowers the seizure threshold and carries a serotonin-syndrome risk with serotonergic drugs such as SSRIs, SNRIs and certain antidepressants and triptans.
  • Like other opioids it can cause dependence and respiratory depression, with additive risk alongside benzodiazepines and other CNS depressants.

Monitoring

Monitor older patients for pain control, sedation, confusion, constipation and signs of serotonin toxicity, and review continued need.

Counselling the patient

  • It can cause drowsiness and dizziness; take care with driving and standing up.
  • Do not combine with alcohol or other sedatives, and report agitation, tremor or a fast heartbeat.

Evidence & guidelines

General prescribing guidance and the SPC highlight tramadol's seizure, serotonergic and CNS risks, supporting cautious reduced-dose use in older adults.

Reference: AGS Beers Criteria 2023; STOPP/START v3; MHRA 2015 (tramadol in children); Drug verified in RxNorm (NLM); confirm dosing against the manufacturer SPC (eMC). Verify against your local formulary and current prescribing references before prescribing. Monograph status: clinician-reviewed (2026-07-04).

Related

Curated clinical cross-links plus same-class fallbacks.